CARbon Impact of aNesthesic Gas
NCT04163848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2021-01-27
Summary
Assessing the impact of anesthesia practice on global warming and carbon footprint becomes part of the standard of care and is growing concern within the anesthesia community. Global Warming Potential (GWP) is a measure of how much a given mass of greenhouse gas contributes to global warming over a specified time period. Inhaled anesthetics have various GWP20: 349 for sevoflurane and 3714 for desflurane. However, GWP20 and CDE20 alone are not sufficient to evaluate the environmental impact of anesthetic gases. Other parameters must be included in the analysis: fresh gas flow (FGF), carrier gas (air, O2, N2O) and potency of the anesthetic gas. Unfortunately, the majority of trials did not fully consider the FGF reduction and the fact that desflurane can be administered with new closed or very low-flow anesthesia circuits as opposed as the recommended 2L/min that must be used for sevoflurane according to its monography in Canada. Most of the calculations were made on a purely theoretical approach that could be different from actual measurements based on a strictly monitored anesthesia practice. When continuous and accurate gas monitoring and analysis is used as recommended nowadays, the use of closed or semi-closed-circuit anesthesia with very low FGF might allow for a reduction of more than 80% of the anesthetic gas administration and its consequent pollution. By properly monitoring the anesthesia depth and analgesia adequacy, the investigators can reduce the gas consumption. The proposed study will aim at determining whether with the help of high-quality monitoring (BIS and NOL) and high-end ventilators that allow minimal fresh gas flow, the use of desflurane remains more polluting than sevoflurane.
Conditions
- Gas; Inhalation
- Anesthesia
Interventions
- OTHER
-
Pollution
CO2 equivalent productions related to anesthetic gases use during general anesthesia for laparoscopic surgery
Sponsors & Collaborators
-
Ciusss de L'Est de l'Île de Montréal
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-25
- Primary Completion
- 2020-01-23
- Completion
- 2020-01-23
Countries
- Canada
Study Locations
More Related Trials
-
Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort
NCT02096224 ·Status: COMPLETED ·Phase: NA
-
Sevoflurane Wash in Method Using Conventional Flows Versus Low Flows of 0.5L
NCT06209112 ·Status: COMPLETED
-
SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia
NCT02201134 ·Status: COMPLETED ·Phase: NA
-
Decreasing Environmental Impact and Costs of Using Inhalational Anesthetic With a Carbon Dioxide Membrane Filter System
NCT04210570 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia
NCT04271462 ·Status: COMPLETED
-
Effect on Cerebral Oxygenation by Sevoflurane or Propofol Using Near-infrared Spectroscopy in Carotid Endarterectomy
NCT02609087 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries
NCT02054143 ·Status: COMPLETED ·Phase: PHASE4
-
Ventilatory Effect on Speed of Anesthesia Under Various Inhaled Anesthetics
NCT01171833 ·Status: COMPLETED ·Phase: NA
-
Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project
NCT01379664 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Desflurane vs. Sevoflurane and the Time to Awakening and the Incidence and Severity of Cough
NCT01202162 ·Status: COMPLETED ·Phase: NA
-
Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth
NCT05024084 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimization of Desflurane in Elderly Patients
NCT01700907 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Anesthetics on Microcirculation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery
NCT03209193 ·Status: COMPLETED ·Phase: PHASE4
-
Sevoflurane Versus Propofol on Optic Nerve Sheath Diameter During Anesthesia in Steep Trendelenburg Position
NCT04289090 ·Status: UNKNOWN ·Phase: PHASE4
-
Volatile Anesthetic Pharmacokinetics During Extracorporeal Membrane Oxygenation
NCT05680545 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nitrous Oxide Added at the End of Sevoflurane Anesthesia and Recovery
NCT03420586 ·Status: COMPLETED ·Phase: NA
-
Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery
NCT00336401 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients
NCT06108973 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Sevoflurane Consumption During General Anesthesia When Using the MemsorbTM Membrane
NCT04539405 ·Status: COMPLETED
-
The Effects of Sevoflurane and Desflurane Used in Low-Flow Anesthesia on Thiol Disulfide Homeostasis
NCT06810453 ·Status: COMPLETED ·Phase: NA
-
The Relationship of Sevoflurane Consumption With Metabolic Age
NCT06018597 ·Status: COMPLETED
-
Hemodynamics for Equi-MAC Anesthesia
NCT03570164 ·Status: COMPLETED ·Phase: NA
-
A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients
NCT02048683 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension
NCT02834845 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Sevoflurane Versus Desflurane Anesthesia Under Protective Mechanical Ventilation for Robotic Assisted Surgery
NCT07304479 ·Status: RECRUITING ·Phase: NA